slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 13,621-13,650
Pages 1,437
Rows per page 30
Arc
13,621-13,650 of 43,093
05
The diagram uses a circular flow to represent the business development and revenue cycle.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Business Model1 hit
07
arm | Investor Presentation Deck | 18 slidesarm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Market Size1 hit
17
The chart uses a dual-axis approach to correlate financial metrics with headcount growth.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Financials1 hit
05
The slide uses a hierarchical structure to connect a high-level objective to three distinct operational pillars.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
10
The slide uses a split-layout: left side defines the condition and market size, right side outlines the clinical and regulatory pain points.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a line chart to demonstrate clinical efficacy over 12 weeks.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses chemical structures and bar charts to contrast the two enantiomers.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Competition1 hit
37
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Financials1 hit
07
The slide uses a structured table to map platforms to candidates, indications, and specific upcoming milestones.BioNTech | Results Presentation Deck | 11 slides · BioNTech
Conference presentation Investor relations Beat · Key TakeawaysLoop · Why Now1 hit
08
BioNTech | Results Presentation Deck | 11 slidesBioNTech | Results Presentation Deck | 11 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
10
BioNTech | Results Presentation Deck | 11 slidesBioNTech | Results Presentation Deck | 11 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
04
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Team1 hit
05
The slide serves as a company overview/fact sheet.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Team1 hit
08
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Problem1 hit
01
Electronic Arts | Results Presentation Deck | 12 slidesElectronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · Setup1 hit
02
Electronic Arts | Results Presentation Deck | 12 slidesElectronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · Setup1 hit
03
Includes a vertical dashed line indicating the transition from ASC 605 to ASC 606 accounting standards.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
04
The slide compares Q4 FY18, Q4 FY19, and Q4 FY20 performance.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
05
The chart displays both quarterly snapshots and trailing 12-month aggregates with year-over-year growth percentages.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
06
The slide includes a disclaimer regarding forward-looking statements and the scope of the list.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · Development1 hit
07
The slide uses a logo-grid layout to showcase the portfolio.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · Development1 hit
08
The slide includes a disclaimer regarding forward-looking statements and the basis of the financial estimates.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
09
The slide includes a disclaimer regarding forward-looking statements and the basis of the financial data.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
10
Includes a disclaimer regarding the change in mobile bookings reporting methodology.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
Includes disclaimer text regarding forward-looking statements and hedging program impact.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
12
The table includes a calculation reference column (A, B, A-B) for Free Cash Flow derivation.Electronic Arts | Results Presentation Deck | 12 slides · Electronic Arts
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
07
The diagram uses a circular flow process to represent the R&D pipeline stages.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank Beat · Solution1 hit
08
The slide uses a Gantt-style chart to show clinical trial progression for various assets.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank Beat · Product1 hit
10
The slide uses a grid layout to present headshots, names, titles, and company logos for 13 executives.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank Beat · Team1 hit
12
Includes Kaplan-Meier survival curve and geographic incidence data.Legend Biotech | IPO Presentation Deck | 42 slides · Legend Biotech
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit